BBLGBone Biologics Corporation

$2M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$733,107

Net Income

-$684,643

EPS (Diluted)

$-0.63

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$714,762

Free Cash Flow

-$714,757

Stock-Based Comp.

$45,674

Balance Sheet

Total Assets

$6M

Total Liabilities

$418,587

Stockholders' Equity

$5M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$733,107	-$2M	+52.9%
Net Income	-$684,643	-$2M	+55.0%

BBLG Q4 2025 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena